Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Comet Monitoring Device

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (2)

Research Network

Common Treatments

  • Comet Monitoring Device1
  • Comet Measurement System1

Active Sponsors

  • Leiden University Medical Center1
  • Photonics Healthcare B.V., Utrecht, The Netherlands1
  • Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research1
  • Rick Hulskes1

Top Investigators

Related Conditions

  • Measurement Error1
  • Surgical Site Infection1
  • Healthy1

Activity Timeline